Friday, July 10, 2009

Yahoo! News: Weight Loss News

Yahoo! News: Weight Loss News


Anti-obesity product safe in mid-stage study (Reuters)

Posted: 09 Jul 2009 04:36 PM PDT

Reuters - Amylin Pharmaceuticals Inc said on Thursday a mid-stage study of its combination obesity product involving versions of hormones linked to appetite and metabolism yielded positive results.

Amylin obesity treatment trial fails to impress (Reuters)

Posted: 09 Jul 2009 12:10 PM PDT

Reuters - Amylin Pharmaceuticals Inc said on Thursday a mid-stage study of its combination obesity treatment yielded positive results, but investors were unimpressed and the company's stock rose just 1 percent.

No comments:

Post a Comment